GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Organics Ltd (NSE:MEDIORG) » Definitions » Capex-to-Operating-Cash-Flow

Medicamen Organics (NSE:MEDIORG) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicamen Organics Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Medicamen Organics's Capital Expenditure for the six months ended in Mar. 2024 was ₹-2.78 Mil. Its Cash Flow from Operations for the six months ended in Mar. 2024 was ₹-32.01 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Medicamen Organics Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Medicamen Organics's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Organics Capex-to-Operating-Cash-Flow Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Cash-Flow
- 16.48 - -

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Capex-to-Operating-Cash-Flow - - - - -

Competitive Comparison of Medicamen Organics's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicamen Organics's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Capex-to-Operating-Cash-Flow falls into.


;
;

Medicamen Organics Capex-to-Operating-Cash-Flow Calculation

Medicamen Organics's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-3.464) / -36.885
=N/A

Medicamen Organics's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.778) / -32.009
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicamen Organics  (NSE:MEDIORG) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Medicamen Organics Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medicamen Organics's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Organics Business Description

Traded in Other Exchanges
N/A
Address
Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd is engaged in developing, manufacturing, and distribution of broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer/third party manufacturer. The company markets its product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis.

Medicamen Organics Headlines

No Headlines